Please provide your email address to receive an email when new articles are posted on . The U.S. Federal Trade Commission voted 3-2 on Feb. 19 to approve the $2 billion merger between Fresenius ...

Please provide your email address to receive an email when new articles are posted on . Fresenius Medical Care and NxStage Medical have agreed to extend the timeline for closing of Fresenius’s $2 ...

The issuer is solely responsible for the content of this announcement. Fresenius Medical Care, the world's largest provider of dialysis products and services, has successfully completed the ...

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Merger Fresenius Medical Care and NxStage extend merger end-date due to government shutdown 29.01.2019 / 14:07 The issuer is solely ...

Find out why concerns about the dialysis specialist's merger are getting worse. NxStage hasn't made a regular press release with quarterly financial results since it received its buyout bid from ...

NxStage Medical (NASDAQ: NXTM) has been in limbo since mid-2017, when it received an offer from Fresenius Medical Care (NYSE: FMS) to buy the company. Since then, shares of NxStage have stayed ...

Fresenius Medical Care (NYSE:FMS) reports that it is still in the process of securing U.S. Federal Trade Commission sign-off for its merger with NXStage Medical, adding that it expects the transaction ...